Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 2:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Pulmonary Arterial Hypertension (PAH), Exercise Therapy
Interventions: Home exercise program; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Autonomic Nervous System Disorders, Pure Autonomic Failure, Shy-Drager Syndrome, Orthostatic Hypotension, Dysautonomic
Interventions: Angiotensin-(1-7), Saline; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Glaucoma
Interventions: glaucoma medications (Timolol, Brimonidine, Dorzolamide, Brinzolamide); Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 85 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity, Hyperlipidemia, Hypertension
Interventions: Antioxidant diet, Antioxidant supplement, Placebo; Behavioral · Dietary Supplement
Lead sponsor: Christopher Gardner; Other
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Stanford, California

Conditions: Postpartum Pregnancy-Induced Hypertension, Postpartum Preeclampsia, Hypertension, Pregnancy-Induced, Hypertension
Interventions: Furosemide, Placebo; Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension, Genetics Hypertension
Interventions: Eplerenone vs Amlodipine; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: SMI, HEI, UC; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years and older
Enrollment: 533 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Arterial Hypertension
Interventions: Dose A KER-012, Dose B KER-012, Dose C KER-012, Placebo for 24 Weeks followed by Dose B KER-012 for 72 weeks; Biological
Lead sponsor: Keros Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 16
States / cities: Scottsdale, Arizona • Tucson, Arizona • Stanford, California + 12 more

Conditions: Acute Brain Injury, Pupillary Reflex Impaired
Interventions: pupillometry; Other
Lead sponsor: University of Milano Bicocca; Other
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 4
States / cities: San Francisco, California • Baltimore, Maryland • Seattle, Washington

Conditions: Hypertension, Pulmonary
Interventions: sildenafil, placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 24
States / cities: Birmingham, Alabama • La Jolla, California • Los Angeles, California + 15 more

Conditions: Normal Tension Glaucoma
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years to 101 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: New York, New York

Conditions: Diabetes Mellitus, Hypertension, Hyperlipidemia
Interventions: Cognitive Behavioral Intervention, Office System Redesign Intervention; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Blood Pressure, Low Back Pain, Hypertension
Interventions: Permanent Epidural Spinal Cord Stimulation; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Gut Inflammation, Hypertension
Interventions: Gene Expression; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hypertension, Hyperlipidemia, Coronary Artery Disease, Diabetes Mellitus
Interventions: Education; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 282 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Exfoliation Syndrome, Ocular Hypertension, Open Angle Glaucoma
Interventions: AR-12286; Drug
Lead sponsor: Robert Ritch, MD, LLC.; Other
Eligibility: 50 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Liver Failure, Intracranial Hypertension
Interventions: Hypothermia by the use of Blanketrol II, Cincinnati Sub-Zero; Device
Lead sponsor: Copenhagen University Hospital, Rigshospitalet; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Kidney Disease, Hypertension
Interventions: Timing of return of results; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6,789 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 14
States / cities: Birmingham, Alabama • Gainesville, Florida • Jacksonville, Florida + 7 more

Conditions: Cardiovascular Diseases, Heart Diseases, Hypertension
Interventions: Mindfulness Meditation (MM) Program, Health Education Control Program (CTL), Lifeskills Program (LP); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 14 Years to 17 Years
Enrollment: 283 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Open Angle Glaucoma, Ocular Hypertension
Interventions: NCX 470 0.1%, Latanoprost 0.005%; Drug
Lead sponsor: Nicox Ophthalmics, Inc.; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 696 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 63
States / cities: Dothan, Alabama • Chandler, Arizona • Phoenix, Arizona + 54 more

Conditions: Respiratory Impairment, Elevated Blood Pressure, Physical Inactivity
Interventions: Increased lifestyle walking (intervention), Health education only (control); Other
Lead sponsor: Iowa State University; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Ames, Iowa

Conditions: Pulmonary Arterial Hypertension
Interventions: imatinib mesylate, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 33
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 25 more

Conditions: Hypertension,Essential, White Coat Hypertension
Interventions: Multifaceted Implementation Strategy, Usual care; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 1,186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: New York, New York

Conditions: Pulmonary Arterial Hypertension
Interventions: Home Rehabilitation Monitoring System, Health coaching calls; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

PAH Exercise Study

Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure

Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma

Effects of Dietary Antioxidants on Cardiovascular Risk Factors

Lasix for the Prevention of De Novo Postpartum Hypertension

Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN

A Behavioral Intervention To Improve Hypertension Control In Veterans

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Outcome pRognostication of Acute Brain Injury With the NeuroloGical Pupil indEx

A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension

A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure

Reducing Clinical Inertia in Diabetes Care

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

Gut Organoid and Microbiome Interactions in Hypertension

Veterans Service Organizations and My HealtheVet (MHV)

A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma

Hypothermia to Prevent High Intracranial Pressure in Patients With Acute Liver Failure

Genetic Testing to Understand and Address Renal Disease Disparities Across the United States

Effects of Behavioral Stress Reduction Programs on Blood Pressure in African American Youth

MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Walking and Blood Pressure in Older Adults With Respiratory Impairment.

Imatinib (QTI571) in Pulmonary Arterial Hypertension

Implementing Hypertension Screening Guidelines in Primary Care

Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension